Recordati
Jonathan shares Roberto ’ s views on the supply chain : “ Components that would previously take three-tosix months were taking 18 months , or even longer , to arrive . Part of this was due to the demand that mass COVID-19 vaccine production placed on available materials in the supply chain . On the other hand , vaccine production shed a positive light on the pharmaceutical industry as a whole . People began to appreciate and value the crucial role of the industry in wider society , especially as countries began to reopen after the pandemic !”
Fernando adds , “ From the manufacturing point of view , in order to mitigate potential future supply issues , we are currently running numerous projects to enhance efficiency and increase our service levels . Overall , the main objective is to continue being a reliable , trustworthy partner for our portfolio of customers and therefore ultimately our patients .” Moving forward , the company ’ s goals for the future are not driven by profits or numbers , but instead driven by people . “ The major goal is to ensure that our patients are not going to suffer from our lack of supply or product availability ,” says Roberto . “ As with any other company , we must ensure we can generate enough contribution to sustain all our current activities . In terms of future investment , this will be guided by our patients and how we can further improve their lives .” ■
www . recordati . com
manufacturing-today . com 163